<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="protocol"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id><journal-id journal-id-type="hwp">bmjopen</journal-id><journal-id journal-id-type="publisher-id">bmjopen</journal-id><journal-title-group><journal-title>BMJ Open</journal-title></journal-title-group><issn pub-type="epub">2044-6055</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30928934</article-id><article-id pub-id-type="pmc">6475359</article-id><article-id pub-id-type="publisher-id">bmjopen-2018-024555</article-id><article-id pub-id-type="doi">10.1136/bmjopen-2018-024555</article-id><article-categories><subj-group subj-group-type="heading"><subject>Gastroenterology and Hepatology</subject><subj-group><subject>Protocol</subject></subj-group></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject><subject>1695</subject></subj-group></article-categories><title-group><article-title>Impact of red meat, processed meat and fibre intake on risk of late-onset chronic inflammatory diseases: prospective cohort study on lifestyle factors using the Danish &#x02018;Diet, Cancer and Health&#x02019; cohort (PROCID-DCH): <italic>protocol</italic>
</article-title></title-group><contrib-group><contrib id="author-61961865" contrib-type="author"><name><surname>Rasmussen</surname><given-names>Nathalie Fogh</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib id="author-61979745" contrib-type="author"><name><surname>Rubin</surname><given-names>Katrine Hass</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib id="author-62916488" contrib-type="author"><name><surname>Stougaard</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib id="author-24453499" contrib-type="author"><name><surname>Tj&#x000f8;nneland</surname><given-names>Anne</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib id="author-62916431" contrib-type="author"><name><surname>Stenager</surname><given-names>Egon</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib id="author-27577004" contrib-type="author"><name><surname>Lund Hetland</surname><given-names>Merete</given-names></name><xref ref-type="aff" rid="aff7">7</xref></contrib><contrib id="author-36746865" contrib-type="author"><name><surname>Glintborg</surname><given-names>Bente</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref></contrib><contrib id="author-55844856" contrib-type="author"><name><surname>Bygum</surname><given-names>Anette</given-names></name><xref ref-type="aff" rid="aff9">9</xref></contrib><contrib id="author-55844517" contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0127-2863</contrib-id><name><surname>Andersen</surname><given-names>Vibeke</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="aff" rid="aff11">11</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<institution content-type="department">Faculty of Health Sciences</institution>, <institution>Aarhus University</institution>, <addr-line content-type="city">Aarhus</addr-line>, <country>Denmark</country>
</aff><aff id="aff2">
<label>2</label>
<institution content-type="department">Focused Research Unit for Molecular Diagnostic and Clinical Research, IRS-Center Sonderjylland</institution>, <institution>Hospital of Southern Jutland</institution>, <addr-line content-type="city">Aabenraa</addr-line>, <country>Denmark</country>
</aff><aff id="aff3">
<label>3</label>
<institution content-type="department">OPEN - Odense Patient Data Explorative Network, Department of Clinical Research</institution>, <institution>University of Southern Denmark, and Odense University Hospital</institution>, <addr-line content-type="city">Odense</addr-line>, <country>Denmark</country>
</aff><aff id="aff4">
<label>4</label>
<institution content-type="department">Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen &#x000d8;, Denmark/Department of Public Health, Faculty of Health and Medical Sciences</institution>, <institution>University of Copenhagen</institution>, <addr-line content-type="city">Copenhagen</addr-line>, <country>Denmark</country>
</aff><aff id="aff5">
<label>5</label>
<institution content-type="department">Department of Regional Health Research</institution>, <institution>University of Southern Denmark</institution>, <addr-line content-type="city">Odense</addr-line>, <country>Denmark</country>
</aff><aff id="aff6">
<label>6</label>
<institution content-type="department">The Multiple Sclerosis Clinic of Southern Jutland (Sonderborg, Kolding, Esbjerg), Department of Neurology</institution>, <institution>Hospital of Southern Jutland</institution>, <addr-line content-type="city">Sonderborg</addr-line>, <country>Denmark</country>
</aff><aff id="aff7">
<label>7</label>
<institution content-type="department">DANBIO Registry/Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics</institution>, <institution>Rigshospitalet Glostrup</institution>, <addr-line content-type="city">Glostrup</addr-line>, <country>Denmark</country>
</aff><aff id="aff8">
<label>8</label>
<institution content-type="department">Department of Rheumatology</institution>, <institution>Gentofte Hospital</institution>, <addr-line content-type="city">Hellerup</addr-line>, <addr-line content-type="state">Hovedstaden</addr-line>, <country>Denmark</country>
</aff><aff id="aff9">
<label>9</label>
<institution content-type="department">Department of Dermatology and Allergy Centre</institution>, <institution>Odense Universitetshospital</institution>, <addr-line content-type="city">Odense</addr-line>, <country>Denmark</country>
</aff><aff id="aff10">
<label>10</label>
<institution content-type="department">Focused Research Unit for Molecular Diagnostic and Clinical Research</institution>, <institution>Hospital of Southern Jutland</institution>, <addr-line content-type="city">Aabenraa</addr-line>, <country>Denmark</country>
</aff><aff id="aff11">
<label>11</label>
<institution content-type="department">institute og molecular medicine</institution>, <institution>Syddansk Universitet Det Sundhedsvidenskabelige Fakultet</institution>, <addr-line content-type="city">Odense</addr-line>, <country>Denmark</country>
</aff><author-notes><corresp><label>Correspondence to</label> Professor Vibeke Andersen; <email>vandersen@health.sdu.dk</email></corresp></author-notes><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>30</day><month>3</month><year>2019</year></pub-date><volume>9</volume><issue>3</issue><elocation-id>e024555</elocation-id><history><date date-type="received"><day>01</day><month>6</month><year>2018</year></date><date date-type="rev-recd"><day>08</day><month>12</month><year>2018</year></date><date date-type="accepted"><day>18</day><month>2</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="bmjopen-2018-024555.pdf"/><self-uri content-type="reviewers-comments-pdf" xlink:href="bmjopen-2018-024555.reviewer_comments.pdf"/><self-uri content-type="draft-revisions-pdf" xlink:href="bmjopen-2018-024555.draft_revisions.pdf"/><abstract><sec><title>Introduction</title><p>Chronic inflammatory diseases (CIDs) (Crohn&#x02019;s disease, ulcerative colitis, psoriasis, psoriatic arthritis, rheumatoid arthritis and multiple sclerosis) are diseases of the immune system that have some shared genetic and environmental predisposing factors, but still few studies have investigated the effects of lifestyle on disease risk of several CIDs. The primary aim of this prospective cohort study is to investigate the impact of fibre, red meat and processed meat on risk of late-onset CID, with the perspective that results of this study can contribute in supporting future diet recommendations for effective personalised prevention.</p></sec><sec><title>Methods and analysis</title><p>The study will use data from 57&#x02009;053 persons from the prospective Danish cohort study &#x02018;Diet, Cancer and Health&#x02019; together with National Health Registry data. The follow-up period is from December 1993 to December 2018. Questionnaire data on diet and lifestyle were collected at entry to the Diet, Cancer and Health study. The outcome CID is defined as having a diagnosis of one of the CIDs registered in the National Patient Registry or, for multiple sclerosis, in the Danish Multiple Sclerosis Registry during follow-up and being treated with a drug used for the specific disease. The major outcome of the analyses will be to detect variability in risk of late onset of any CID and, if power allows, disease risk of late onset of each CID diagnosis between persons with different fibre and red meat, and processed meat intake. The outcome will be adjusted for age, sex, body mass index, physical activity, energy, alcohol, fermented dairy products, education, smoking status, hormone replacement therapy and comorbidity.</p></sec><sec><title>Ethics and dissemination</title><p>The study is approved by the Danish Data Protection Agency (2012-58-0018). The core study is an open register-based cohort study. The study does not need approval from the Ethics committee or Institutional Review Board by Danish law. Study findings will be disseminated through peer-reviewed journals, patient associations and presentations at international conferences.</p></sec><sec><title>Trial registration number</title><p>NCT03456206; Post-results.</p></sec></abstract><kwd-group><kwd>lifestyle</kwd><kwd>diet</kwd><kwd>chronic inflammatory diseases</kwd><kwd>disease risk</kwd><kwd>fibre</kwd><kwd>red meat</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>special-feature</meta-name><meta-value>unlocked</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Strengths and limitations of this study</title></caption><list list-type="bullet"><list-item><p>The linkage to Danish national registers will ensure almost complete follow-up of the study population, as the Danish registries are considered of high validity and completeness.</p></list-item><list-item><p>The big sample size will enable a sufficient power of the total late-onset chronic inflammatory disease (CID) group even when taking loss to emigration and competing risk of death into account.</p></list-item><list-item><p>The study includes several CIDs.</p></list-item><list-item><p>Risk of low specificity of the diagnostic codes and treatment codes as criteria for identifying late-onset CID cases.</p></list-item><list-item><p>Prospective studies including younger age groups are necessary to reveal the generalisability of the results.</p></list-item></list></boxed-text><sec id="s1"><title>Introduction</title><p>The chronic inflammatory diseases (CIDs) can be considered as systemic diseases which primarily affect one organ such as the intestine (inflammatory bowel disease [IBD]: Crohn&#x02019;s disease [CD] and colitis ulcerosa [UC]), skin (psoriasis [PsO]), joints (rheumatoid arthritis [RA] and psoriatic arthritis [PsA]) or the brain (multiple sclerosis [MS]).</p><p>The peak of disease&#x000a0;onset is in the adult phase of life. The diseases have a large impact on the patients and their families&#x02019; quality of life due to lack of causative treatment, and on the society due to the&#x000a0;absence from work and on healthcare economy due to lack of preventative measures.<xref rid="R1" ref-type="bibr">1&#x02013;7</xref> The CIDs have a high prevalence, with IBD and MS affecting, respectively, 0.5% and 0.1% of the population in the Western world.<xref rid="R8" ref-type="bibr">8&#x02013;12</xref> Studies from across the world have reported prevalence estimates of RA and PsO ranging from 0.3% to 1.0% and 0.7% to 3.2%,&#x02009;respectively,<xref rid="R2" ref-type="bibr">2 8 13&#x02013;15</xref> while the prevalence of PsA is estimated as 0.04%&#x02013;0.25% across countries.<xref rid="R14" ref-type="bibr">14 16</xref> Furthermore, one-third of patients with RA are diagnosed at&#x000a0;&#x0003e;60 years of age<xref rid="R17" ref-type="bibr">17</xref> and the incidence of late-onset IBD and MS has been reported to increase.<xref rid="R18" ref-type="bibr">18 19</xref>
</p><p>The CIDs have some shared genetic<xref rid="R20" ref-type="bibr">20&#x02013;24</xref> and environmental (eg, smoking, gut microbiome) predisposing factors, and causes of the high incidence and prevalence point to such environmental factors.<xref rid="R8" ref-type="bibr">8 25&#x02013;40</xref> Therefore, further research of the associations between potential modifiable environmental risk factors and risk of CID is important.</p><sec id="s1a"><title>Evidence-based research</title><p>It has been demonstrated that a high level of red meat consumption is a risk factor for the development of inflammatory polyarthritis (including RA).<xref rid="R39" ref-type="bibr">39 40</xref> A high-fibre intake has been associated with low risk of IBD.<xref rid="R27" ref-type="bibr">27</xref> Furthermore, several studies of the impact of dietary factors on MS point towards an impact of meat preservation such as smoking or addition of nitrites.<xref rid="R41" ref-type="bibr">41&#x02013;44</xref> Studies have also suggested other lifestyle factors such as physical activity,<xref rid="R45" ref-type="bibr">45&#x02013;47</xref> body mass index (BMI),<xref rid="R1" ref-type="bibr">1 47&#x02013;49</xref> smoking status<xref rid="R50" ref-type="bibr">50&#x02013;56</xref> and other dietary factors such as alcohol,<xref rid="R1" ref-type="bibr">1 57&#x02013;59</xref> dairy products<xref rid="R38" ref-type="bibr">38</xref> and glycaemic index<xref rid="R60" ref-type="bibr">60 61</xref> to be associated with CIDs. Furthermore, studies have shown that the interactions among the microbiota, female sexual hormones and immunity are associated with the development of autoimmune diseases.<xref rid="R62" ref-type="bibr">62</xref>
</p><p>There are many potential mechanisms whereby the&#x000a0;environment such as diet may affect the immune system (<xref ref-type="fig" rid="F1">figure 1</xref>). Recently, we provided the hypothesis that intake of high fibre/low red and processed meat may protect against CID.<xref rid="R61" ref-type="bibr">61</xref>
<xref ref-type="fig" rid="F1">Figure 1</xref> presents a model, proposed in a previous study,<xref rid="R8" ref-type="bibr">8</xref> whereby a diet high in meat and low in fibres may impact inflammation.</p></sec><sec id="s1b"><title>Aims and hypotheses</title><p>Based on previous evidence, we set out to prospectively identify dietary factors that have an impact on disease risk of late-onset CID.</p><p>The primary aim of this prospective cohort study is to investigate the impact of fibre, red meat and processed meat on disease risk outcomes of late-onset CID in the &#x02018;Diet, Cancer and Health&#x02019; (DCH) cohort. The overall perspectives are that results from this study will be contributing in supporting future diet recommendations for effective personalised prevention of individuals identified to be at high risk.</p><p>The main hypothesis is that &#x02018;the risk of late-onset CID will be significantly lower among those with a high fibre/low red meat, and processed meat intake compared with those with a low fibre/high red meat and processed meat intake.&#x02019; The hypothesis is illustrated in <xref ref-type="fig" rid="F1">figure 1</xref>.</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Hypothesis for effects of diet in relation to the&#x000a0;development of chronic inflammatory diseases (CIDs). Diet (meat,<xref rid="R97" ref-type="bibr">97</xref> fibre,<xref rid="R97" ref-type="bibr">97</xref> animal fat,<xref rid="R98" ref-type="bibr">98</xref> n-3<xref rid="R30" ref-type="bibr">30</xref> and n-6 polyunsaturated fatty acids, vitamins A<xref rid="R99" ref-type="bibr">99</xref> and D,<xref rid="R100" ref-type="bibr">100</xref> carotenoids,<xref rid="R101" ref-type="bibr">101</xref> smoking, gluten<xref rid="R102" ref-type="bibr">102</xref>) may affect the immune system<xref rid="R103" ref-type="bibr">103 104</xref> either directly or indirectly via, for&#x000a0;example, the activity and composition of the gut microbiome.<xref rid="R105" ref-type="bibr">105 106</xref> The effect of low intake of fibre/high intake of red and processed meat is shown at left: in short, low intake of fibre (which could otherwise serve as a nutrient for the microbes) may lead to the microbial metabolism of mucus and to decrease of the intestinal mucus layer.<xref rid="R61" ref-type="bibr">61 107 108</xref> A high intake of red and processed meat may render the mucus layer penetrable to, for&#x000a0;example, bacteria by reducing the disulphide bonds in the mucus network.<xref rid="R8" ref-type="bibr">8 105 109</xref> Thus, microbes may reach the epithelium<xref rid="R8" ref-type="bibr">8 110 111</xref> and activate the immune system.<xref rid="R8" ref-type="bibr">8 112 113</xref> There is some support for such a mechanism in CIDs,<xref rid="R8" ref-type="bibr">8</xref> including findings of; high amounts of sulphate-reducing bacteria in patients with inflammatory bowel disease (IBD)<xref rid="R8" ref-type="bibr">8 111 114</xref>; association of high-fibre intake with low risk of IBD among 170 776 participants from the prospective Nurses&#x02019; Health Study I<xref rid="R8" ref-type="bibr">8 27</xref>; and association of high intake of red meat and total protein and risk of developing inflammatory polyarthritis in the population-based prospective cohort of 25 630 participants from the European Prospective Investigation of Cancer in Norfolk.<xref rid="R8" ref-type="bibr">8 39 40</xref> IEC, intestinal epithelial cell; MAMPs, microbe-associated molecular patterns; NFkB, nuclear factor kappa-light-chain-enhancer of activated B cells; TLRs, toll-like receptors; TNF, tumor necrosis factor. Figure from Christensen <italic>et&#x000a0;al</italic>
<xref rid="R8" ref-type="bibr">8</xref> (copyright 2018 by Vibeke Andersen).</p></caption><graphic xlink:href="bmjopen-2018-024555f01"/></fig><p>Based on previous research on a shared aetiology in CIDs, we hypothesise that &#x02018;the suggested association between high fibre/low red meat, and processed meat intake and risk of developing CID is applicable for each of the CID diagnoses&#x02019;.</p><p>The secondary aim of this prospective cohort study is to investigate whether risk of late-onset CID in the DCH cohort is affected by other dietary and lifestyle differences, and therefore to adjust for the potential confounders: age, sex, BMI, physical activity, energy, alcohol intake, intake of fermented dairy products, education after basic school, hormone replacement therapy (HRT), smoking status and comorbidity.</p></sec></sec><sec id="s2"><title>Methods and analyses</title><sec id="s2a"><title>Design and setting</title><p>This study is an observational study using prospective registry follow-up data. We will use the Danish cohort &#x02018;DCH&#x02019;, and the follow-up period will be from the date of entry in the DCH cohort (between December 1993 and May 1997) until December&#x000a0;2018.</p><p>The DCH study is an ongoing Danish cohort study designed to investigate the relation between diet, lifestyle and disease risk.<xref rid="R63" ref-type="bibr">63</xref> The cohort consists of 57&#x000a0;053 persons, recruited between December 1993 and May 1997. All the subjects (50&#x02013;64 years of age) gave detailed information on diet (Food Frequency Questionnaire [FFQ]) and other lifestyle data. Questionnaire data on diet and lifestyle were collected at study entry.<xref rid="R63" ref-type="bibr">63</xref> Data from the DCH cohort will be combined with Danish health registries (the National Patient Registry [NPR], the Danish Civil Registration System [CRS], The Danish National Prescription Registry [DNPR] and the Danish Multiple Sclerosis Registry [DMSR]).</p></sec><sec id="s2b"><title>Participant characteristics and eligibility criteria</title><p>Criteria for inclusion: the population to be studied include participants in the DCH cohort.<xref rid="R63" ref-type="bibr">63</xref> In short, the criteria for invitation to the DCH cohort were: age between 50 and 64, born in Denmark, and no diagnosis of cancer registered in the Danish Cancer Registry. All persons fulfilling these criteria and living in the areas of Copenhagen and Aarhus were invited.<xref rid="R63" ref-type="bibr">63</xref>
</p><p>Criteria for exclusion: participants registered in NPR or DMSR with a CID primary diagnosis from a department with relevant area of specialisation in the period between 1977 and entry to the DCH cohort will be excluded regardless of whether the person receive medical treatment for CID or not.</p></sec><sec id="s2c"><title>The Danish health registries</title><p>We will extract data from the four national registries in those time periods that is possible for each registry: NPR from 1977&#x000a0;to&#x000a0;2018, CRS from 1977&#x000a0;to&#x000a0;2018, DNPR from 1994&#x000a0;to&#x000a0;2018 and DMSR from 1977&#x000a0;to&#x000a0;2018. An overview of the information obtained from the different registries is presented in <xref rid="T1" ref-type="table">table 1</xref>.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Overview of registry information</p></caption><table frame="hsides" rules="groups"><thead><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Variable</td><td valign="bottom" align="left" rowspan="1" colspan="1">Definition</td><td valign="bottom" align="left" rowspan="1" colspan="1">Registry</td><td valign="bottom" align="left" rowspan="1" colspan="1">Time period</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">CPR</td><td valign="top" align="left" rowspan="1" colspan="1">Civil Registration Number</td><td valign="top" align="left" rowspan="1" colspan="1">CRS</td><td valign="top" align="char" char="ndash" rowspan="1" colspan="1">1977&#x02013;2018</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ICD-10 code*</td><td valign="top" align="left" rowspan="1" colspan="1">International Classification of Diseases</td><td valign="top" align="left" rowspan="1" colspan="1">NPR</td><td valign="top" align="char" char="ndash" rowspan="1" colspan="1">1994&#x02013;2018</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ICD-8 code*</td><td valign="top" align="left" rowspan="1" colspan="1">International Classification of Diseases</td><td valign="top" align="left" rowspan="1" colspan="1">NPR</td><td valign="top" align="char" char="ndash" rowspan="1" colspan="1">1977&#x02013;1993</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Medication (ATC code)</td><td valign="top" align="left" rowspan="1" colspan="1">Anatomical Therapeutic Chemical classification (ATC) code</td><td valign="top" align="left" rowspan="1" colspan="1">DNPR</td><td valign="top" align="char" char="ndash" rowspan="1" colspan="1">1994&#x02013;2018</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Treatment code</td><td valign="top" align="left" rowspan="1" colspan="1">Medical treatment classification code</td><td valign="top" align="left" rowspan="1" colspan="1">NPR</td><td valign="top" align="char" char="ndash" rowspan="1" colspan="1">1994&#x02013;2018</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Department with relevant area of specialisation</td><td valign="top" align="left" rowspan="1" colspan="1">Medical and gastroenterological department (IBD), medical and rheumatological department (RA, PsA), Medical and dermatological department (PsA, PsO)</td><td valign="top" align="left" rowspan="1" colspan="1">NPR</td><td valign="top" align="char" char="ndash" rowspan="1" colspan="1">1977&#x02013;2018</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ICD-8 and ICD-10 codes for multiple sclerosis (MS)</td><td valign="top" align="left" rowspan="1" colspan="1">Diagnostic codes for MS</td><td valign="top" align="left" rowspan="1" colspan="1">DMSR</td><td valign="top" align="char" char="ndash" rowspan="1" colspan="1">1977&#x02013;2018</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>*ICD-8 and ICD-10 codes in the period 1977&#x02013;1997 will be used to define chronic inflammatory disease diagnosis.</p></fn><fn id="tblfn2"><p>CRS, The Danish Civil Registration System; DMSR,&#x000a0;Danish Multiple Sclerosis Registry; DNPR,&#x000a0;Danish National Prescription Registry; IBD,&#x000a0;inflammatory bowel disease; NPR,&#x000a0;National Patient Registry; PsA, psoriatic arthritis; PsO,&#x000a0;psoriasis; RA,&#x000a0;rheumatoid arthritis.</p></fn></table-wrap-foot></table-wrap><p>The NPR will be used to identify patients with CID during follow-up and, in addition, patients with CID before study entry. The NPR contains data on all patients admitted to Danish hospitals since 1977. The register covers both inpatient and outpatient records and indicates the main medical reason for diagnostic procedures or treatment (since 1971 according to the eight version and 1994 according to the tenth version of the International Classification of Diseases [ICD-8 and ICD-10]). ICD-8 and ICD-10 codes will be used to identify cases diagnosed before entry to the DCH cohort study. Information on the departments with the relevant areas of specialisation will be obtained from the NPR and used to identify cases as described in the Data analysis section.</p><p>The DMSR will be used to identify patients with MS during follow-up, and in addition, patients with MS before study entry.</p><p>The DNPR will be used to obtain information on the medical treatment according to the Anatomical Therapeutic Chemical classification (ATC) code.</p><p>From the CRS, we will extract follow-up information on civil status, death and immigration.</p><p>Data will be linked by the unique identification number assigned to all residents in Denmark at birth or first immigration which provides a unique opportunity to link information about diagnoses, medications, etc., at the individual level.</p></sec><sec id="s2d"><title>Outcome and exposures</title><p>Outcome:&#x000a0;in this study, the outcome <italic>late-onset CID</italic> is defined as one of the following diseases: CD, UC, PsO, PsA, RA or MS. This outcome is defined by fulfilling the following two criteria: (1) having the CID disease in NPR (except MS) from a department with relevant area of specialisation, or in the DMSR (MS) during the follow-up period and (2) being treated (irrespective of the number of treatments) with a drug used for the specific disease, and the treatment being registered either in the DNPR or from a department with relevant area of specialisation (criterion 2 will not apply to MS). The outcome late-onset CIDs with the associated ICD-8 and ICD-10 codes and the ATC codes in DNPR and treatment codes in the NPR are specified in <xref rid="T2" ref-type="table">table 2</xref>. The date and year of the diagnosis are defined as the date and year of the diagnosis in NPR and/or DMSR. If a patient has several CID diseases, only time to the first diagnosis will be included in the analyses.</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Specification of outcome chronic inflammatory diseases (CIDs) with associated diagnostic&#x000a0;code and treatment codes</p></caption><table frame="hsides" rules="groups"><thead><tr><td valign="bottom" rowspan="2" align="left" colspan="1">CID</td><td valign="bottom" colspan="2" align="left" rowspan="1">Diagnostic code (NPR)</td><td valign="bottom" colspan="2" align="left" rowspan="1">Medical treatment (DNPR and NPR)</td><td valign="bottom" rowspan="2" align="left" colspan="1">Department with relevant area of specialisation</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">ICD-8*</td><td valign="bottom" align="left" rowspan="1" colspan="1">ICD-10</td><td valign="bottom" align="left" rowspan="1" colspan="1">ATC code (DNPR)&#x02020;</td><td valign="bottom" align="left" rowspan="1" colspan="1">Treatment code (NPR)&#x02020;</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Crohn&#x02019;s disease (CD)</td><td valign="top" align="left" rowspan="1" colspan="1">563.00, 563.02, <break/>563.08, <break/>563.09, <break/>563.91</td><td valign="top" align="left" rowspan="1" colspan="1">K50.0&#x02013;50.9</td><td valign="top" rowspan="2" align="left" colspan="1">L04AB02 <break/>L04AB04 <break/>L04AB06 <break/>L04AB05 <break/>L04AA33 <break/>L04A&#x000d7;01 <break/>L04A&#x000d7;03 <break/>L01BB02 <break/>A07E</td><td valign="top" rowspan="2" align="left" colspan="1">BOHJ18A1 <break/>BOHJ18A3 <break/>BOHJ18A4 <break/>BOHJ18A5 <break/>BOHJ26 <break/>BOHJ19H4</td><td valign="top" align="left" rowspan="1" colspan="1">Gastroenterology, <break/>internal medicine</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Ulcerative colitis (UC)</td><td valign="top" align="left" rowspan="1" colspan="1">563.99, 563.19 <break/>569.04</td><td valign="top" align="left" rowspan="1" colspan="1">K51.0&#x02013;51.9</td><td valign="top" align="left" rowspan="1" colspan="1">Gastroenterology, <break/>internal medicine</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Chronic polyarthritis, including RA</td><td valign="top" align="left" rowspan="1" colspan="1">712.19, 712.29, 712.39, 712.59</td><td valign="top" align="left" rowspan="1" colspan="1">M05.9, M06.0</td><td valign="top" rowspan="2" align="left" colspan="1">L04A&#x000d7;01 <break/>L04A&#x000d7;03 <break/>L04AA13 <break/>P01BA02</td><td valign="top" rowspan="2" align="left" colspan="1">BWHA115 <break/>BLHM2 <break/>BWHB83 <break/>BOHJ18</td><td valign="top" align="left" rowspan="1" colspan="1">Rheumatology, internal medicine</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Psoriatic arthritis</td><td valign="top" align="left" rowspan="1" colspan="1">696.09</td><td valign="top" align="left" rowspan="1" colspan="1">M09.0, M07.3, M46.8+M07.2</td><td valign="top" align="left" rowspan="1" colspan="1">Rheumatology, <break/>internal medicine</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Psoriasis</td><td valign="top" align="left" rowspan="1" colspan="1">696.10, 696.19</td><td valign="top" align="left" rowspan="1" colspan="1">L40.0&#x02013;40.9</td><td valign="top" align="left" rowspan="1" colspan="1">D05A&#x000d7;02 <break/>D05BB02 <break/>D05B <break/>L04AA32 <break/>L04AB01-02 <break/>L04AB04 <break/>L04AC05 <break/>L04AC10 <break/>L04AC13 <break/>L04AD01 <break/>L04A&#x000d7;03</td><td valign="top" align="left" rowspan="1" colspan="1">BWHA115 <break/>BOHJ20 <break/>BNHC <break/>BOHJ18A1-3 <break/>BOHJ18B3 <break/>BOHJ18B5</td><td valign="top" align="left" rowspan="1" colspan="1">Dermatology, <break/>internal medicine</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Multiple sclerosis (MS)</td><td valign="top" align="left" rowspan="1" colspan="1">734.0&#x02013;9&#x02021;</td><td valign="top" align="left" rowspan="1" colspan="1">G35.9&#x02021;</td><td valign="top" align="left" rowspan="1" colspan="1">Not used</td><td valign="top" align="left" rowspan="1" colspan="1">Not used</td><td valign="top" align="left" rowspan="1" colspan="1">Danish Multiple Sclerosis Registry&#x000a0;(DMSR)</td></tr></tbody></table><table-wrap-foot><fn id="tblfn3"><p>*International Classification of Disease (ICD)-8 and ICD-10 codes will be used to define participants with a CID diagnosis.</p></fn><fn id="tblfn4"><p>&#x02020;These Anatomical Therapeutic Chemical classification (ATC) and treatment codes for CD and UC are used by the Danish National Registry for Biological Therapy in Inflammatory Bowel Disease.<xref rid="R98" ref-type="bibr">98</xref>
</p></fn><fn id="tblfn5"><p>&#x02021;ICD-8 and ICD-10 codes for MS will be extracted from the DMSR.</p></fn><fn id="tblfn6"><p>DNPR, Danish National Prescription Registry; NPR, National Patient Registry; RA, rheumatoid arthritis.</p></fn></table-wrap-foot></table-wrap><p>Exposure and possible confounders: information on exposure in this study is defined as high-fibre intake and high red meat, and processed meat intake, and also other dietary and lifestyle factors.</p><p>In the DCH study, information on diet and lifestyle exposure was collected at enrolment using questionnaires as has been described in detail elsewhere.<xref rid="R63" ref-type="bibr">63</xref> In short, in the FFQ diet consumption was assessed in 12 categories of predefined responses, ranking from &#x02018;never&#x02019; to &#x02018;eight times or more per day over the past 12 months&#x02019;. The daily intake was then calculated by FoodCalc.<xref rid="R63" ref-type="bibr">63</xref> Both intake of dietary fibre and red meat and processed meat were measured as continues variable in g/day. The initially collected data on diet and lifestyle exposure of the DCH cohort is used as the baseline information on exposure in this study.</p><p>Information on dietary and lifestyle exposures used for this study is specified in <xref rid="T3" ref-type="table">table 3</xref>. Fibres, red meat and processed meat are defined based on the classification of the food items in the DCH study,<xref rid="R63" ref-type="bibr">63</xref> and with inspiration from other studies using dietary data from the DCH cohort.<xref rid="R64" ref-type="bibr">64&#x02013;66</xref> Red meat is defined as fresh and minced meat (unprocessed) from beef, veal, pork and lamb and excluding poultry, fish and eggs. Processed meat consists of red meat, poultry and fish items that have undergone processing such as smoking, salting or curing. This includes various kinds of sausages, salami, smoked or cooked ham, poultry or fish, other cold cuts, bacon and liver pate. Poultry includes chicken and turkey both unprocessed and processed, such as various cold cuts of chicken and turkey. Fish includes all unprocessed and processed fish as well as shellfish. Total meat is defined as the total of red (unprocessed) meat, red processed meat together with poultry and fish.<xref rid="R64" ref-type="bibr">64&#x02013;66</xref> Fibres are defined as fibres from fibrous food items from the FFQ.</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Specification of exposures and overall food groups and lifestyle factors</p></caption><table frame="hsides" rules="groups"><thead><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Variable</td><td valign="bottom" align="left" rowspan="1" colspan="1">Definition (unit)</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Diet</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Total energy intake</td><td valign="top" align="left" rowspan="1" colspan="1">kJ/day</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Total meat</td><td valign="top" align="left" rowspan="1" colspan="1">g/day</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Red meat</td><td valign="top" align="left" rowspan="1" colspan="1">g/day</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Red, processed meat</td><td valign="top" align="left" rowspan="1" colspan="1">g/day</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Fish (fresh and processed)</td><td valign="top" align="left" rowspan="1" colspan="1">g/day</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Poultry (fresh and processed)</td><td valign="top" align="left" rowspan="1" colspan="1">g/day</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Total dietary fibre intake</td><td valign="top" align="left" rowspan="1" colspan="1">g/day</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Legumes</td><td valign="top" align="left" rowspan="1" colspan="1">g/day</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Vegetables</td><td valign="top" align="left" rowspan="1" colspan="1">g/day</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Fruits</td><td valign="top" align="left" rowspan="1" colspan="1">g/day</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Cereals</td><td valign="top" align="left" rowspan="1" colspan="1">g/day</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Dairy products</td><td valign="top" align="left" rowspan="1" colspan="1">g/day</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Lifestyle factors</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Alcohol intake</td><td valign="top" align="left" rowspan="1" colspan="1">Units of alcohol/week*</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Smoking status</td><td valign="top" align="left" rowspan="1" colspan="1">Yes/no</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Former smoker</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Current smoker</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Never smoker</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Metabolic equivalent of task (MET) score (physical activity)</td><td valign="top" align="left" rowspan="1" colspan="1">hours/week</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Body mass index</td><td valign="top" align="left" rowspan="1" colspan="1">kg/cm<sup>2</sup>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Highest education after basic school</td><td valign="top" align="left" rowspan="1" colspan="1">Yes/no</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Vocational education</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Higher education 1&#x02013;2&#x02009;years</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Higher education 3&#x02013;4&#x02009;years</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Higher education&#x000a0;&#x0003e;4&#x02009;years</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Comorbidity (Charlson Comorbidity Index)</td><td valign="top" align="left" rowspan="1" colspan="1">Index score</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Hormone replacement therapy</td><td valign="top" align="left" rowspan="1" colspan="1">Yes/no</td></tr></tbody></table><table-wrap-foot><fn id="tblfn7"><p>*One unit of alcohol is defined as 12 g of pure alcohol.</p></fn></table-wrap-foot></table-wrap><p>Information on possible confounders will also be obtained from the questionnaire data at enrolment in relation to sex, age, education after basic school, BMI, physical activity, energy, HRT, comorbidity, smoking status, alcohol intake and also intake of fermented dairy products. The Charlsons Comorbidity Index<xref rid="R67" ref-type="bibr">67</xref> will be used to classify comorbidity among the study participants. ICD-8 and ICD-10 codes from the NPR will be used to calculate the Charlson score, using the updated Charlson Comorbidity Index.<xref rid="R68" ref-type="bibr">68</xref>
</p><p>Primary exposure variable: the primary exposure variables will be analysed in tertiles. Based on the hypothesis that the risk of CID and late-onset CID will be lower among those with a high fibre/low red meat, and processed meat intake compared to those with a low fibre/high red meat, and processed meat intake, it is expected that<list list-type="bullet"><list-item><p>The upper tertile of the sample (33.3% of the total sample), based on the ratio of fibre/meat intake, is associated with lower risk of CID and late-onset CID.</p></list-item><list-item><p>The lower tertile of the sample (33.3% of the total sample) with respect to intake of red meat and processed meat and the upper tertile of the sample (33.3% of the total sample) with respect to intake of dietary fibres are independently associated with lower risk of CID and late-onset CID, and a potential interaction between them may further lower the risk of CID and late-onset CID.</p></list-item></list>
</p><p>Other (exploratory) exposure variables:<list list-type="bullet"><list-item><p>Other dietary and lifestyle factors independently or combined will be analysed, and are presented in <xref rid="T3" ref-type="table">table 3</xref>.</p></list-item></list>
</p></sec><sec id="s2e"><title>Statistical analysis plan</title><p>The data obtained from this study will be used to investigate our ability to predict risk of late-onset CID, based on whether a diet high in fibre and low in red meat, and processed meat is a predictive factor. Furthermore, data on other lifestyle factors and dietary factors obtained from the FFQ will be used to investigate whether these factors potentially could give rise to confounding of the association between fibre/meat intake and risk of late-onset CID.</p><p>Descriptive analyses for categorical variables will be presented as frequencies, and differences between late-onset CID cases and non-cases will be evaluated by&#x000a0;&#x003c7;<sup>2</sup> test. Continuous variables will be tabulated as medians (with quartiles, Q1 and Q3) and non-parametric tests on the equality of medians will be used to test for differences between groups. P&#x000a0;values below 0.05 will be considered statistically significant. Negative binomial regression will be applied to calculate incidence rates per 1000 patient years and incidence rate ratios between exposures. To investigate the risk of and time to CID diagnosis, the Fine-Gray competing risk regression model will be applied, and thus competing risk of death will be taken into account while handling emigration as censoring and reporting cumulative incidences and sub-HRs and the corresponding p&#x000a0;values for late-onset CID associated with specified food substitutions. Regressions will be carried out as both crude regressions, only including the exposure, and adjusted for age, sex, lifestyle factors and selected comorbidities. Sensitivity analyses of the outcome variable and use of medication will be carried out.</p><p>Logistic regression will be conducted to examining the association between fibre/meat intake and already being diagnosed with a CID diagnose. Analyses will be conducted using Stata V.15.<xref rid="R69" ref-type="bibr">69</xref>
</p><p>If power of each of the disease groups allows, there will be conducted subanalyses on each of the late-onset CID diagnoses separately with the overall aim of testing if the hypothesised association between diet factors and development of late-onset CID is applicable for all the late-onset CIDs or if some of the late-onset CIDs deviate from this association. Moreover, analyses omitting MS from the overall definition of CID will be performed.</p><p>Information on the departments with the relevant areas of specialisation will be used to evaluate the robustness of the diagnosis codes from the NPR and to identify the cases as we will only accept cases that have a diagnosis from a relevant department. The DMSR is highly validated,<xref rid="R70" ref-type="bibr">70</xref> and data from the registry will be used to ensure complete follow-up of valid diagnoses of MS.</p><p><italic>Power considerations, late-onset CID</italic>: the age-adjusted (age between 45&#x000a0;and&#x000a0;69) incidences per 100&#x02009;000 years of the CIDs in Denmark are 10.1&#x02013;10.6 for CD<xref rid="R71" ref-type="bibr">71</xref>; 27.5&#x02013;32.7 for UC<xref rid="R71" ref-type="bibr">71</xref>; 200&#x02013;225 for PsO<xref rid="R15" ref-type="bibr">15</xref>; 28&#x02013;35 for PsA<xref rid="R16" ref-type="bibr">16</xref>; 4.4&#x02013;7.5 for MS<xref rid="R19" ref-type="bibr">19 72&#x02013;75</xref> and 28.1&#x02013;57.6 for RA.<xref rid="R76" ref-type="bibr">76 77</xref> In the cohort of approximately 57&#x02009;000 participants and a follow-up period of approximately 20 years, these incidences correspond to an estimate of approximately 2000 cases of CID in the cohort. To estimate the power of the study, we therefore expect approximately 2000 cases of CID, that is, an incidence of about 3% and about one-third of the cohort in the low risk and two-thirds in the high-risk exposure. Assuming a fixed follow-up of 20 years and a relevant effect size of 2% CID risk in the low-risk exposure compared with 3% in the high-risk exposure, this would require 11&#x02009;667 participants to obtain a power of 0.90 in an (unadjusted) &#x003c7;<sup>2</sup> test. Hence, with a total cohort size of approximately 57&#x000a0;000, this should ensure a sufficient power even when taking loss to emigration and competing risk of death (resulting in less than 20-year follow-up for some participants) into account.</p></sec><sec id="s2f"><title>Patient and public involvement</title><p>This study is register based and there will be no patients or public involvement in the study.</p></sec><sec id="s2g"><title>Strengths and limitations of the study</title><p>A strength of this study is that it is not limited to one disease, as it includes several CIDs. Another strength is that the linkage to Danish health registries will ensure almost complete follow-up of the study population, as the Danish health registries are considered the internationally most comprehensive with high validity.<xref rid="R78" ref-type="bibr">78&#x02013;81</xref> Furthermore, in this study, we have chosen very restrictive criteria for defining the late-onset CID cases by requiring that cases fulfil both diagnostic and treatment criteria, or that the cases were registered in the DMSR. This approach ensures that a high proportion of the identified cases really had late-onset CID. Therefore, some &#x02018;real&#x02019; CID cases might not have been identified, hence lowering the sensitivity.<xref rid="R70" ref-type="bibr">70 82 83</xref>
</p><p>A possible limitation of this study could have been the validity of the diagnostic codes from the NPR and the treatment codes from the DNPR as criteria for identifying late-onset CID cases.<xref rid="R70" ref-type="bibr">70 82</xref> But, as described in the analysis plan, this potential limitation will be sought eliminated by using the information on the hospital departments, and for MS, using the DMSR for identifying MS cases. In addition, usually dietary habits do not change much during life. Therefore, the exposure time to the diet is long in 50+age&#x02009;group and a possible impact of diet is possibly located much earlier in life. Therefore, we have included an analysis among those who at entry to the DCH cohort already had a CID diagnosis to examine if their low/high intake of dietary fibre, red meat and processed meat is associated with having CID. We are well aware that such an analysis might be impacted by bias by indication and that the results should be interpreted with this in mind.</p><p>The FFQ applied in the present study has been used in the large, European prospective cohort study &#x02018;The European Prospective Investigation into Cancer and Nutrition&#x02019; (EPIC),<xref rid="R84" ref-type="bibr">84 85</xref> and it has been used and evaluated in the Danish population, with results that demonstrate consistency.<xref rid="R86" ref-type="bibr">86&#x02013;88</xref> However, the FFQ is not without limitations, with respect to the lack of information on portion sizes<xref rid="R89" ref-type="bibr">89 90</xref> or to underestimation and overestimation of intake of unhealthy and healthy food.<xref rid="R91" ref-type="bibr">91</xref> Any imprecision of the FFQ due to standardised portion sizes or incorrect reporting of food intake, will lead to large CIs, which potentially can lead to null results.<xref rid="R8" ref-type="bibr">8</xref> On the other hand, studies suggest that specification of a standard portion size may not introduce a large error in the estimation of food and nutrient intake.<xref rid="R92" ref-type="bibr">92</xref> Furthermore, the FFQ has been validated as being appropriate for use in studies that examine relationships between diet and risk of disease.<xref rid="R91" ref-type="bibr">91</xref>
</p><p>Another limitation of this study is the validity of the information on exposure as this information is collected at study entry, which potentially can be several years before any outcome appears, and measurement error in the FFQ may occur if the participants change their diet over time. Furthermore, there is a potential risk of recall bias according to the information on exposure, as this information relies on the participants&#x02019; ability to recall their dietary intake. In this study, however, it is expected that dietary and lifestyle patterns among adults are relatively stable over time, based on other longitudinal studies that showed minimal temporal changes.<xref rid="R93" ref-type="bibr">93 94</xref>
</p><p>The MET&#x000a0;score is an accepted standard measure of physical activity.<xref rid="R95" ref-type="bibr">95</xref> However, the weaknesses of the MET&#x000a0;score include a risk of adding random variation by applying an assumed intensity to include activities. Another weakness of the MET&#x000a0;score is the implicit assumption that the intensity aspect of physical activity is important for the&#x000a0;development of disease.<xref rid="R95" ref-type="bibr">95</xref>
</p><p>The study population in this study is based on a cohort of middle-aged women and men living in urban areas. This could reduce the generalisability of study findings, as the incidence of CID diagnoses could be different for younger persons and persons from rural areas.</p><p>The disease groups may be heterogeneous regarding dietary and lifestyle factors. This study may not capture every dietary and lifestyle difference between the disease groups, due to insufficient power of each disease group, as described in the analysis plan. Replication of the results in other well-characterised populations using prospectively sampled dietary data will minimise the risk of potential type 2 errors. Study results should preferably be replicated in cohorts in other countries and other age groups for further evaluation of the robustness of the results.</p></sec><sec id="s2h"><title>Project organisation</title><p>This registry study is a cross-disciplinary collaboration that includes clinical specialists within neurology, dermatology, rheumatology, IBDs, prospective cohort study design and clinical registries.</p></sec><sec id="s2i"><title>Perspectives</title><p>We anticipate that the PROCID-DCH study will reveal factors of importance, including whether the diet is likely to interfere with the disease risk of late-onset CID.</p><p>The perspective is that significant results from this study will be sought replicated in other cohorts such as the EPIC-IBD<xref rid="R84" ref-type="bibr">84</xref> and UK biobank<xref rid="R96" ref-type="bibr">96</xref> with high-quality prospective lifestyle data. Successful replication indicates the robustness of the findings which is an important step on the road to developing clinical tools for effective personalised prevention of individuals at high risk.</p></sec><sec id="s2j"><title>Dissemination of results to the public and scientifically</title><p>Target journals include international journals within internal medicine. In addition to the scientific reporting of results, major findings with translational implications will also be communicated to categories of both health professionals, and targeted stakeholders including public health policy-makers, and to the general public through various media and news activities. Intellectual Property Rights to discoveries based on the outlined research belong to the University of Southern Denmark.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="d35e378"><caption><title>Reviewer comments</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="bmjopen-2018-024555.reviewer_comments.pdf"/></supplementary-material><supplementary-material content-type="local-data" id="d35e379"><caption><title>Author's manuscript</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="bmjopen-2018-024555.draft_revisions.pdf"/></supplementary-material></sec></body><back><fn-group><fn fn-type="other"><p><bold>Contributors:</bold> VA conceived the presented idea and achieved funding. AT (diet and environmental factors, epidemiology) designed the cohort, collected the data and made the data available for the present project. NFR, KHR, MS and VA wrote the first draft and contributed to the further preparation and final adjustments of the protocol. According to their respective specialisation, all other authors, ES (multiple sclerosis), MLH (rheumatology), BG (rheumatology) and AB (psoriasis) contributed to the project. All authors discussed the results and contributed to the final manuscript.</p></fn><fn fn-type="other"><p><bold>Funding:</bold> This work is supported by Region of Southern Denmark grant number [17/33849] (Vibeke Andersen), and the Danish Rheumatism Association (R150-A4434-B760, Vibeke Andersen).</p></fn><fn fn-type="COI-statement"><p><bold>Competing interests:</bold> BG declares to have received research funding from Abbvie, Biogen, Pfizer. MLH declares to have received research funding from BMS, MSD, Pfizer, Biogen, Samsung, CellTrion, Lilly and Novartis. AB has participated in the development of educational material for Biogen. All other authors declare no conflict of interest.</p></fn><fn fn-type="other"><p><bold>Ethics approval:</bold> This is an open register-based cohort study. The study does not need approval from the local Ethics committee or Institutional Review Board by Danish law. The study was approved by the Danish Data Protection Agency (2012-58-0018).</p></fn><fn fn-type="other"><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn><fn fn-type="other"><p><bold>Patient consent for publication:</bold> Obtained.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Amato</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Derfuss</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hemmer</surname><given-names>B</given-names></name>, <etal>et al</etal></person-group>
<article-title>Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop</article-title>. <source>Mult Scler</source>
<year>2017</year>:<fpage>1</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1177/1352458516686847</pub-id>
</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Parisi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Symmons</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Griffiths</surname><given-names>CE</given-names></name>, <etal>et al</etal></person-group>
<article-title>Global epidemiology of psoriasis: a systematic review of incidence and prevalence</article-title>. <source>J Invest Dermatol</source>
<year>2013</year>;<volume>133</volume>:<fpage>377</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1038/jid.2012.339</pub-id>
<pub-id pub-id-type="pmid">23014338</pub-id></mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Baumgart</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Carding</surname><given-names>SR</given-names></name></person-group>
<article-title>Gastroenterology 1: Inflammatory bowel disease: cause and immunobiology</article-title>. <source>The Lancet</source>
<year>2007</year>;<volume>369</volume>:<fpage>1627</fpage>.</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Baumgart</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Sandborn</surname><given-names>WJ</given-names></name></person-group>
<article-title>Inflammatory bowel disease: clinical aspects and established and evolving therapies</article-title>. <source>The Lancet</source>
<year>2007</year>;<volume>369</volume>:<fpage>1641</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(07)60751-X</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Strober</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Fuss</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Mannon</surname><given-names>P</given-names></name></person-group>
<article-title>The fundamental basis of inflammatory bowel disease</article-title>. <source>J Clin Invest</source>
<year>2007</year>;<volume>117</volume>:<fpage>514</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1172/JCI30587</pub-id>
<pub-id pub-id-type="pmid">17332878</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Taurog</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Chhabra</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Colbert</surname><given-names>RA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Ankylosing spondylitis and axial spondyloarthritis</article-title>. <source>N Engl J Med</source>
<year>2016</year>;<volume>374</volume>:<fpage>2563</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1406182</pub-id>
<pub-id pub-id-type="pmid">27355535</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>L&#x000f6;fvendahl</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Theander</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Svensson</surname><given-names>&#x000c5;</given-names></name>, <etal>et al</etal></person-group>
<article-title>Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden&#x02013;a population-based register study</article-title>. <source>PLoS One</source>
<year>2014</year>;<volume>9</volume>:<elocation-id>e98024</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0098024</pub-id>
<pub-id pub-id-type="pmid">24875275</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Christensen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Heitmann</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Andersen</surname><given-names>KW</given-names></name>, <etal>et al</etal></person-group>
<article-title>Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicine</article-title>. <source>BMJ Open</source>
<year>2018</year>;<volume>8</volume>:<elocation-id>e018166</elocation-id>
<pub-id pub-id-type="doi">10.1136/bmjopen-2017-018166</pub-id>
</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Molodecky</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Soon</surname><given-names>IS</given-names></name>, <name name-style="western"><surname>Rabi</surname><given-names>DM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review</article-title>. <source>Gastroenterology</source>
<year>2012</year>;<volume>142</volume>:<fpage>46</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2011.10.001</pub-id>
<pub-id pub-id-type="pmid">22001864</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Leray</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Moreau</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Fromont</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Epidemiology of multiple sclerosis</article-title>. <source>Rev Neurol</source>
<year>2016</year>;<volume>172</volume>:<fpage>3</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurol.2015.10.006</pub-id>
<pub-id pub-id-type="pmid">26718593</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Browne</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Chandraratna</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Angood</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group>
<article-title>Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity</article-title>. <source>Neurology</source>
<year>2014</year>;<volume>83</volume>:<fpage>1022</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000000768</pub-id>
<pub-id pub-id-type="pmid">25200713</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Hamidi</surname><given-names>N</given-names></name>, <etal>et al</etal></person-group>
<article-title>Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies</article-title>. <source>Lancet</source>
<year>2018</year>;<volume>390</volume>:<fpage>2769</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(17)32448-0</pub-id>
<pub-id pub-id-type="pmid">29050646</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="web">
<collab>WHO</collab>. <article-title>Chronic Diseases and Health Promotion</article-title>. <year>2017</year>
<uri xlink:href="http://www.who.int/chp/topics/rheumatic/en/">http://www.who.int/chp/topics/rheumatic/en/</uri>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Poddubnyy</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rudwaleit</surname><given-names>M</given-names></name></person-group>
<article-title>Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis</article-title>. <source>Expert Opin Drug Saf</source>
<year>2011</year>;<volume>10</volume>:<fpage>655</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1517/14740338.2011.581661</pub-id>
<pub-id pub-id-type="pmid">21554150</pub-id></mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Egeberg</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Skov</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gislason</surname><given-names>GH</given-names></name>, <etal>et al</etal></person-group>
<article-title>Incidence and Prevalence of Psoriasis in Denmark</article-title>. <source>Acta Derm Venereol</source>
<year>2017</year>;<volume>97</volume>:<fpage>808</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.2340/00015555-2672</pub-id>
<pub-id pub-id-type="pmid">28417141</pub-id></mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Egeberg</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kristensen</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Thyssen</surname><given-names>JP</given-names></name>, <etal>et al</etal></person-group>
<article-title>Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study</article-title>. <source>Ann Rheum Dis</source>
<year>2017</year>;<volume>76</volume>:<fpage>1591</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2016-210963</pub-id>
<pub-id pub-id-type="pmid">28483767</pub-id></mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Olivieri</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Palazzi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Peruz</surname><given-names>G</given-names></name>, <etal>et al</etal></person-group>
<article-title>Management issues with elderly-onset rheumatoid arthritis: an update</article-title>. <source>Drugs Aging</source>
<year>2005</year>;<volume>22</volume>:<fpage>809</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.2165/00002512-200522100-00002</pub-id>
<pub-id pub-id-type="pmid">16245956</pub-id></mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Taleban</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Colombel</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Mohler</surname><given-names>MJ</given-names></name>, <etal>et al</etal></person-group>
<article-title>Inflammatory bowel disease and the elderly: a review</article-title>. <source>J Crohns Colitis</source>
<year>2015</year>;<volume>9</volume>:<fpage>507</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjv059</pub-id>
<pub-id pub-id-type="pmid">25870198</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Koch-Henriksen</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Thygesen</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Stenager</surname><given-names>E</given-names></name>, <etal>et al</etal></person-group>
<article-title>Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women</article-title>. <source>Neurology</source>
<year>2018</year>;<volume>90</volume>:<fpage>e1954</fpage>&#x02013;<lpage>e1963</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000005612</pub-id>
<pub-id pub-id-type="pmid">29720546</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Beecham</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Patsopoulos</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Xifara</surname><given-names>DK</given-names></name>, <etal>et al</etal></person-group>
<article-title>Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis</article-title>. <source>Nat Genet</source>
<year>2013</year>;<volume>45</volume>:<fpage>1353</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2770</pub-id>
<pub-id pub-id-type="pmid">24076602</pub-id></mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ellinghaus</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Jostins</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Spain</surname><given-names>SL</given-names></name>, <etal>et al</etal></person-group>
<article-title>Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci</article-title>. <source>Nat Genet</source>
<year>2016</year>;<volume>48</volume>:<fpage>510</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3528</pub-id>
<pub-id pub-id-type="pmid">26974007</pub-id></mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Boucher</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lees</surname><given-names>CW</given-names></name>, <etal>et al</etal></person-group>
<article-title>Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47</article-title>. <source>Nat Genet</source>
<year>2011</year>;<volume>43</volume>:<fpage>246</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1038/ng.764</pub-id>
<pub-id pub-id-type="pmid">21297633</pub-id></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ellinghaus</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zeissig</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Association between variants of PRDM1 and NDP52 and Crohn&#x02019;s disease, based on exome sequencing and functional studies</article-title>. <source>Gastroenterology</source>
<year>2013</year>;<volume>145</volume>:<fpage>339</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2013.04.040</pub-id>
<pub-id pub-id-type="pmid">23624108</pub-id></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Goyette</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Boucher</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mallon</surname><given-names>D</given-names></name>, <etal>et al</etal></person-group>
<article-title>High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis</article-title>. <source>Nat Genet</source>
<year>2015</year>;<volume>47</volume>:<fpage>172</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3176</pub-id>
<pub-id pub-id-type="pmid">25559196</pub-id></mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ananthakrishnan</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Khalili</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Higuchi</surname><given-names>LM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Higher predicted vitamin D status is associated with reduced risk of Crohn&#x02019;s disease</article-title>. <source>Gastroenterology</source>
<year>2012</year>;<volume>142</volume>:<fpage>482</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2011.11.040</pub-id>
<pub-id pub-id-type="pmid">22155183</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ananthakrishnan</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Khalili</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Konijeti</surname><given-names>GG</given-names></name>, <etal>et al</etal></person-group>
<article-title>Long-term intake of dietary fat and risk of ulcerative colitis and Crohn&#x02019;s disease</article-title>. <source>Gut</source>
<year>2014</year>;<volume>63</volume>:<fpage>776</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2013-305304</pub-id>
<pub-id pub-id-type="pmid">23828881</pub-id></mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ananthakrishnan</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Khalili</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Konijeti</surname><given-names>GG</given-names></name>, <etal>et al</etal></person-group>
<article-title>A prospective study of long-term intake of dietary fiber and risk of Crohn&#x02019;s disease and ulcerative colitis</article-title>. <source>Gastroenterology</source>
<year>2013</year>;<volume>145</volume>:<fpage>970</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2013.07.050</pub-id>
<pub-id pub-id-type="pmid">23912083</pub-id></mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ananthakrishnan</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Khalili</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Zinc intake and risk of Crohn&#x02019;s disease and ulcerative colitis: a prospective cohort study</article-title>. <source>Int J Epidemiol</source>
<year>2015</year>;<volume>44</volume>:<fpage>1995</fpage>&#x02013;<lpage>2005</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyv301</pub-id>
<pub-id pub-id-type="pmid">26546032</pub-id></mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ananthakrishnan</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Khalili</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>High School Diet and Risk of Crohn&#x02019;s Disease and Ulcerative Colitis</article-title>. <source>Inflamm Bowel Dis</source>
<year>2015</year>;<volume>21</volume>:<fpage>2311</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/MIB.0000000000000501</pub-id>
<pub-id pub-id-type="pmid">26236952</pub-id></mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Luben</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Olsen</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn&#x02019;s disease</article-title>. <source>Aliment Pharmacol Ther</source>
<year>2014</year>;<volume>39</volume>:<fpage>834</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1111/apt.12670</pub-id>
<pub-id pub-id-type="pmid">24611981</pub-id></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Luben</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Olsen</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Body mass index and the risk for Crohn&#x02019;s disease and ulcerative colitis: data from a European Prospective Cohort Study (The IBD in EPIC Study)</article-title>. <source>Am J Gastroenterol</source>
<year>2013</year>;<volume>108</volume>:<elocation-id>575</elocation-id>&#x02013;<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1038/ajg.2012.453</pub-id>
<pub-id pub-id-type="pmid">23318483</pub-id></mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Luben</surname><given-names>R</given-names></name>, <name name-style="western"><surname>van Schaik</surname><given-names>F</given-names></name>, <etal>et al</etal></person-group>
<article-title>Carbohydrate intake in the etiology of Crohn&#x02019;s disease and ulcerative colitis</article-title>. <source>Inflamm Bowel Dis</source>
<year>2014</year>;<volume>20</volume>:<fpage>2013</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1097/MIB.0000000000000168</pub-id>
<pub-id pub-id-type="pmid">25265262</pub-id></mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>John</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Luben</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Shrestha</surname><given-names>SS</given-names></name>, <etal>et al</etal></person-group>
<article-title>Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study</article-title>. <source>Eur J Gastroenterol Hepatol</source>
<year>2010</year>;<volume>22</volume>:<fpage>602</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1097/MEG.0b013e3283352d05</pub-id>
<pub-id pub-id-type="pmid">20216220</pub-id></mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>de Silva</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Luben</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Shrestha</surname><given-names>SS</given-names></name>, <etal>et al</etal></person-group>
<article-title>Dietary arachidonic and oleic acid intake in ulcerative colitis etiology: a prospective cohort study using 7-day food diaries</article-title>. <source>Eur J Gastroenterol Hepatol</source>
<year>2014</year>;<volume>26</volume>:<fpage>11</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1097/MEG.0b013e328365c372</pub-id>
<pub-id pub-id-type="pmid">24216567</pub-id></mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>de Silva</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Olsen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Christensen</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>An association between dietary arachidonic acid, measured in adipose tissue, and ulcerative colitis</article-title>. <source>Gastroenterology</source>
<year>2010</year>;<volume>139</volume>:<fpage>1912</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2010.07.065</pub-id>
<pub-id pub-id-type="pmid">20950616</pub-id></mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hart</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Luben</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Olsen</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Diet in the aetiology of ulcerative colitis: a European prospective cohort study</article-title>. <source>Digestion</source>
<year>2008</year>;<volume>77</volume>:<fpage>57</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1159/000121412</pub-id>
<pub-id pub-id-type="pmid">18349539</pub-id></mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Opstelten</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Leenders</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dik</surname><given-names>VK</given-names></name>, <etal>et al</etal></person-group>
<article-title>Dairy Products, Dietary Calcium, and Risk of Inflammatory Bowel Disease: Results From a European Prospective Cohort Investigation</article-title>. <source>Inflamm Bowel Dis</source>
<year>2016</year>;<volume>22</volume>:<fpage>1403</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1097/MIB.0000000000000798</pub-id>
<pub-id pub-id-type="pmid">27120568</pub-id></mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bordoni</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Danesi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Dardevet</surname><given-names>D</given-names></name>, <etal>et al</etal></person-group>
<article-title>Dairy products and inflammation: a review of the clinical evidence</article-title>. <source>Crit Rev Food Sci Nutr</source>
<year>2017</year>;<volume>57</volume>:<fpage>2497</fpage>&#x02013;<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1080/10408398.2014.967385</pub-id>
<pub-id pub-id-type="pmid">26287637</pub-id></mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lahiri</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Luben</surname><given-names>RN</given-names></name>, <name name-style="western"><surname>Morgan</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group>
<article-title>Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register&#x02013;the EPIC-2-NOAR Study)</article-title>. <source>Ann Rheum Dis</source>
<year>2014</year>;<volume>73</volume>:<fpage>219</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2012-202481</pub-id>
<pub-id pub-id-type="pmid">23505230</pub-id></mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pattison</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Symmons</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Lunt</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption</article-title>. <source>Arthritis Rheum</source>
<year>2004</year>;<volume>50</volume>:<fpage>3804</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1002/art.20731</pub-id>
<pub-id pub-id-type="pmid">15593211</pub-id></mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lauer</surname><given-names>K</given-names></name></person-group>
<article-title>Multiple sclerosis in relation to meat preservation in France and Switzerland</article-title>. <source>Neuroepidemiology</source>
<year>1989</year>;<volume>8</volume>:<fpage>308</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1159/000110199</pub-id>
<pub-id pub-id-type="pmid">2586701</pub-id></mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lauer</surname><given-names>K</given-names></name></person-group>
<article-title>The food pattern in geographical relation to the risk of multiple sclerosis in the Mediterranean and Near East region</article-title>. <source>J Epidemiol Community Health</source>
<year>1991</year>;<volume>45</volume>:<fpage>251</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1136/jech.45.3.251</pub-id>
<pub-id pub-id-type="pmid">1757770</pub-id></mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lauer</surname><given-names>K</given-names></name></person-group>
<article-title>Notes on the epidemiology of multiple sclerosis, with special reference to dietary habits</article-title>. <source>Int J Mol Sci</source>
<year>2014</year>;<volume>15</volume>:<fpage>3533</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.3390/ijms15033533</pub-id>
<pub-id pub-id-type="pmid">24577315</pub-id></mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lauer</surname><given-names>K</given-names></name></person-group>
<article-title>The history of nitrite in human nutrition: a contribution from German cookery books</article-title>. <source>J Clin Epidemiol</source>
<year>1991</year>;<volume>44</volume>:<fpage>261</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/0895-4356(91)90037-A</pub-id>
<pub-id pub-id-type="pmid">1999685</pub-id></mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sharif</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Watad</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bragazzi</surname><given-names>NL</given-names></name>, <etal>et al</etal></person-group>
<article-title>Physical activity and autoimmune diseases: Get moving and manage the disease</article-title>. <source>Autoimmun Rev</source>
<year>2018</year>;<volume>17</volume>:<fpage>53</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2017.11.010</pub-id>
<pub-id pub-id-type="pmid">29108826</pub-id></mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Kappelman</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>CF</given-names></name>, <etal>et al</etal></person-group>
<article-title>Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission</article-title>. <source>Inflamm Bowel Dis</source>
<year>2015</year>;<volume>21</volume>:<fpage>1063</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1097/MIB.0000000000000333</pub-id>
<pub-id pub-id-type="pmid">25723616</pub-id></mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bilski</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mazur-Bialy</surname><given-names>AI</given-names></name>, <name name-style="western"><surname>Wierdak</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>The impact of physical activity and nutrition on inflammatory bowel disease: the potential role of cross talk between adipose tissue and skeletal muscle</article-title>. <source>J Physiol Pharmacol</source>
<year>2013</year>;<volume>64</volume>:<fpage>143</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">23756389</pub-id></mixed-citation></ref><ref id="R48"><label>48.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wolk</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Mallbris</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Larsson</surname><given-names>P</given-names></name>, <etal>et al</etal></person-group>
<article-title>Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis</article-title>. <source>Acta Derm Venereol</source>
<year>2009</year>;<volume>89</volume>:<fpage>492</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.2340/00015555-0711</pub-id>
<pub-id pub-id-type="pmid">19734975</pub-id></mixed-citation></ref><ref id="R49"><label>49.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Oliver</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Silman</surname><given-names>AJ</given-names></name></person-group>
<article-title>Risk factors for the development of rheumatoid arthritis</article-title>. <source>Scand J Rheumatol</source>
<year>2006</year>;<volume>35</volume>:<fpage>169</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1080/03009740600718080</pub-id>
<pub-id pub-id-type="pmid">16766362</pub-id></mixed-citation></ref><ref id="R50"><label>50.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mahid</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Minor</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Soto</surname><given-names>RE</given-names></name>, <etal>et al</etal></person-group>
<article-title>Smoking and inflammatory bowel disease: a meta-analysis</article-title>. <source>Mayo Clin Proc</source>
<year>2006</year>;<volume>81</volume>:<fpage>1462</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.4065/81.11.1462</pub-id>
<pub-id pub-id-type="pmid">17120402</pub-id></mixed-citation></ref><ref id="R51"><label>51.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Klareskog</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Malmstr&#x000f6;m</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Lundberg</surname><given-names>K</given-names></name>, <etal>et al</etal></person-group>
<article-title>Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis</article-title>. <source>Semin Immunol</source>
<year>2011</year>;<volume>23</volume>:<fpage>92</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.smim.2011.01.014</pub-id>
<pub-id pub-id-type="pmid">21376627</pub-id></mixed-citation></ref><ref id="R52"><label>52.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>HK</given-names></name>, <etal>et al</etal></person-group>
<article-title>Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis</article-title>. <source>Am J Epidemiol</source>
<year>2012</year>;<volume>175</volume>:<fpage>402</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwr325</pub-id>
<pub-id pub-id-type="pmid">22247049</pub-id></mixed-citation></ref><ref id="R53"><label>53.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Costenbader</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Feskanich</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Mandl</surname><given-names>LA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women</article-title>. <source>Am J Med</source>
<year>2006</year>;<volume>119</volume>:<fpage>503.e1</fpage>&#x02013;<lpage>503.e9</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjmed.2005.09.053</pub-id>
<pub-id pub-id-type="pmid">16750964</pub-id></mixed-citation></ref><ref id="R54"><label>54.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Setty</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Curhan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>HK</given-names></name></person-group>
<article-title>Smoking and the risk of psoriasis in women: Nurses' Health Study II</article-title>. <source>Am J Med</source>
<year>2007</year>;<volume>120</volume>:<fpage>953</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjmed.2007.06.020</pub-id>
<pub-id pub-id-type="pmid">17976422</pub-id></mixed-citation></ref><ref id="R55"><label>55.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Alfredsson</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Olsson</surname><given-names>T</given-names></name></person-group>
<article-title>Lifestyle and Environmental Factors in Multiple Sclerosis</article-title>. <source>Cold Spring Harb Perspect Med</source>
<year>2018</year>:<fpage>a028944</fpage> (<comment>published Online First: 2018/05/08</comment>). <pub-id pub-id-type="doi">10.1101/cshperspect.a028944</pub-id>
</mixed-citation></ref><ref id="R56"><label>56.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Palacios</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Alonso</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Br&#x000f8;nnum-Hansen</surname><given-names>H</given-names></name>, <etal>et al</etal></person-group>
<article-title>Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence</article-title>. <source>Ann Epidemiol</source>
<year>2011</year>;<volume>21</volume>:<fpage>536</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.annepidem.2011.03.001</pub-id>
<pub-id pub-id-type="pmid">21550815</pub-id></mixed-citation></ref><ref id="R57"><label>57.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Swanson</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Sedghi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Farhadi</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease</article-title>. <source>Alcohol</source>
<year>2010</year>;<volume>44</volume>:<fpage>223</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.alcohol.2009.10.019</pub-id>
<pub-id pub-id-type="pmid">20682190</pub-id></mixed-citation></ref><ref id="R58"><label>58.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Khasawneh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Spence</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Addley</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>The role of smoking and alcohol behaviour in the management of inflammatory bowel disease</article-title>. <source>Best Pract Res Clin Gastroenterol</source>
<year>2017</year>;<volume>31</volume>:<fpage>553</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpg.2017.10.004</pub-id>
<pub-id pub-id-type="pmid">29195675</pub-id></mixed-citation></ref><ref id="R59"><label>59.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Abdollahpour</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Nedjat</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mansournia</surname><given-names>MA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Lifestyle factors and multiple sclerosis: A population-based incident case-control study</article-title>. <source>Mult Scler Relat Disord</source>
<year>2018</year>;<volume>22</volume>:<fpage>128</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.msard.2018.03.022</pub-id>
<pub-id pub-id-type="pmid">29677591</pub-id></mixed-citation></ref><ref id="R60"><label>60.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Haus</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Solomon</surname><given-names>TP</given-names></name>, <etal>et al</etal></person-group>
<article-title>A low-glycemic index diet and exercise intervention reduces TNF(alpha) in isolated mononuclear cells of older, obese adults</article-title>. <source>J Nutr</source>
<year>2011</year>;<volume>141</volume>:<elocation-id>1089</elocation-id>&#x02013;<lpage>1094</lpage>. <pub-id pub-id-type="doi">10.3945/jn.111.139964</pub-id>
<pub-id pub-id-type="pmid">21525252</pub-id></mixed-citation></ref><ref id="R61"><label>61.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Andersen</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Hansen</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Heitmann</surname><given-names>BL</given-names></name></person-group>
<article-title>Potential Impact of Diet on Treatment Effect from Anti-TNF Drugs in Inflammatory Bowel Disease</article-title>. <source>Nutrients</source>
<year>2017</year>;<volume>9</volume>:<fpage>286</fpage>
<pub-id pub-id-type="doi">10.3390/nu9030286</pub-id>
</mixed-citation></ref><ref id="R62"><label>62.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Vieira</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>Castelo</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Ribeiro</surname><given-names>DA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Influence of Oral and Gut Microbiota in the Health of Menopausal Women</article-title>. <source>Front Microbiol</source>
<year>2017</year>;<volume>8</volume>
<pub-id pub-id-type="doi">10.3389/fmicb.2017.01884</pub-id>
</mixed-citation></ref><ref id="R63"><label>63.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tj&#x000f8;nneland</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Olsen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Boll</surname><given-names>K</given-names></name>, <etal>et al</etal></person-group>
<article-title>Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark</article-title>. <source>Scand J Public Health</source>
<year>2007</year>;<volume>35</volume>:<fpage>432</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1080/14034940601047986</pub-id>
<pub-id pub-id-type="pmid">17786808</pub-id></mixed-citation></ref><ref id="R64"><label>64.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>W&#x000fc;rtz</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Hansen</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Tj&#x000f8;nneland</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Substitution of meat and fish with vegetables or potatoes and risk of myocardial infarction</article-title>. <source>Br J Nutr</source>
<year>2016</year>;<volume>116</volume>:<fpage>1602</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114516003500</pub-id>
<pub-id pub-id-type="pmid">27774916</pub-id></mixed-citation></ref><ref id="R65"><label>65.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>S&#x000f8;rensen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Autrup</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Olsen</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Prospective study of NAT1 and NAT2 polymorphisms, tobacco smoking and meat consumption and risk of colorectal cancer</article-title>. <source>Cancer Lett</source>
<year>2008</year>;<volume>266</volume>:<fpage>186</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2008.02.046</pub-id>
<pub-id pub-id-type="pmid">18372103</pub-id></mixed-citation></ref><ref id="R66"><label>66.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Egeberg</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Olsen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Christensen</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Associations between red meat and risks for colon and rectal cancer depend on the type of red meat consumed</article-title>. <source>J Nutr</source>
<year>2013</year>;<volume>143</volume>:<fpage>464</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.3945/jn.112.168799</pub-id>
<pub-id pub-id-type="pmid">23427329</pub-id></mixed-citation></ref><ref id="R67"><label>67.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Charlson</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Pompei</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ales</surname><given-names>KL</given-names></name>, <etal>et al</etal></person-group>
<article-title>A new method of classifying prognostic comorbidity in longitudinal studies: development and validation</article-title>. <source>J Chronic Dis</source>
<year>1987</year>;<volume>40</volume>:<fpage>373</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/0021-9681(87)90171-8</pub-id>
<pub-id pub-id-type="pmid">3558716</pub-id></mixed-citation></ref><ref id="R68"><label>68.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Quan</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Couris</surname><given-names>CM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries</article-title>. <source>Am J Epidemiol</source>
<year>2011</year>;<volume>173</volume>:<fpage>676</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwq433</pub-id>
<pub-id pub-id-type="pmid">21330339</pub-id></mixed-citation></ref><ref id="R69"><label>69.</label><mixed-citation publication-type="book">
<source>Stata Statistical Software [program]. 15 version</source>, <year>2017</year>.</mixed-citation></ref><ref id="R70"><label>70.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mason</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Thygesen</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Stenager</surname><given-names>E</given-names></name>, <etal>et al</etal></person-group>
<article-title>Evaluating the use and limitations of the Danish National Patient Register in register-based research using an example of multiple sclerosis</article-title>. <source>Acta Neurol Scand</source>
<year>2012</year>;<volume>125</volume>:<fpage>213</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0404.2011.01558.x</pub-id>
<pub-id pub-id-type="pmid">21699500</pub-id></mixed-citation></ref><ref id="R71"><label>71.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lophaven</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Lynge</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Burisch</surname><given-names>J</given-names></name></person-group>
<article-title>The incidence of inflammatory bowel disease in Denmark 1980-2013: a nationwide cohort study</article-title>. <source>Aliment Pharmacol Ther</source>
<year>2017</year>;<volume>45</volume>:<fpage>961</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1111/apt.13971</pub-id>
<pub-id pub-id-type="pmid">28229470</pub-id></mixed-citation></ref><ref id="R72"><label>72.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kingwell</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Marriott</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Jett&#x000e9;</surname><given-names>N</given-names></name>, <etal>et al</etal></person-group>
<article-title>Incidence and prevalence of multiple sclerosis in Europe: a systematic review</article-title>. <source>BMC Neurol</source>
<year>2013</year>;<volume>13</volume>:<elocation-id>128</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2377-13-128</pub-id>
<pub-id pub-id-type="pmid">24070256</pub-id></mixed-citation></ref><ref id="R73"><label>73.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bentzen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Flachs</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Stenager</surname><given-names>E</given-names></name>, <etal>et al</etal></person-group>
<article-title>Prevalence of multiple sclerosis in Denmark 1950&#x02013;2005</article-title>. <source>Mult Scler</source>
<year>2010</year>;<volume>16</volume>:<fpage>520</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1177/1352458510364197</pub-id>
<pub-id pub-id-type="pmid">20215479</pub-id></mixed-citation></ref><ref id="R74"><label>74.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Koch-Henriksen</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Magyari</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Laursen</surname><given-names>B</given-names></name></person-group>
<article-title>Registers of multiple sclerosis in Denmark</article-title>. <source>Acta Neurol Scand</source>
<year>2015</year>;<volume>132</volume>:<fpage>4</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1111/ane.12424</pub-id>
<pub-id pub-id-type="pmid">26046552</pub-id></mixed-citation></ref><ref id="R75"><label>75.</label><mixed-citation publication-type="web">
<collab>Society TDMS</collab>. <article-title>Fakta om sclerose 2013</article-title>. <uri xlink:href="https://scleroseforeningen.dk/viden-og-nyt/hvad581er-sclerose/fa-alle-tallene-om-sclerose">https://scleroseforeningen.dk/viden-og-nyt/hvad581er-sclerose/fa-alle-tallene-om-sclerose</uri> (<comment>accessed May 2018</comment>).</mixed-citation></ref><ref id="R76"><label>76.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kiadaliri</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Kristensen</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Englund</surname><given-names>M</given-names></name></person-group>
<article-title>Burden of rheumatoid arthritis in the Nordic region, 1990-2015: a comparative analysis using the Global Burden of Disease Study 2015</article-title>. <source>Scand J Rheumatol</source>
<year>2018</year>;<volume>47</volume>:<fpage>1</fpage>&#x02013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1080/03009742.2017.1314002</pub-id>
</mixed-citation></ref><ref id="R77"><label>77.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pedersen</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Svendsen</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>H&#x000f8;rslev-Petersen</surname><given-names>K</given-names></name></person-group>
<article-title>Incidence of Rheumatoid Arthritis in the Southern part of Denmark from 1995 to 2001</article-title>. <source>Open Rheumatol J</source>
<year>2007</year>;<volume>1</volume>:<fpage>18</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.2174/1874312900701010018</pub-id>
<pub-id pub-id-type="pmid">19088896</pub-id></mixed-citation></ref><ref id="R78"><label>78.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pedersen</surname><given-names>CB</given-names></name></person-group>
<article-title>The Danish Civil Registration System</article-title>. <source>Scand J Public Health</source>
<year>2011</year>;<volume>39</volume>:<fpage>22</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1177/1403494810387965</pub-id>
<pub-id pub-id-type="pmid">21775345</pub-id></mixed-citation></ref><ref id="R79"><label>79.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Sandegaard</surname><given-names>JL</given-names></name>, <etal>et al</etal></person-group>
<article-title>The Danish National Patient Registry: a review of content, data quality, and research potential</article-title>. <source>Clin Epidemiol</source>
<year>2015</year>;<volume>7</volume>:<fpage>449</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.2147/CLEP.S91125</pub-id>
<pub-id pub-id-type="pmid">26604824</pub-id></mixed-citation></ref><ref id="R80"><label>80.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Potteg&#x000e5;rd</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>SAJ</given-names></name>, <name name-style="western"><surname>Wallach-Kildemoes</surname><given-names>H</given-names></name>, <etal>et al</etal></person-group>
<article-title>Data Resource Profile: The Danish National Prescription Registry</article-title>. <source>Int J Epidemiol</source>
<year>2017</year>;<volume>46</volume>:<fpage>dyw213</fpage>
<pub-id pub-id-type="doi">10.1093/ije/dyw213</pub-id>
</mixed-citation></ref><ref id="R81"><label>81.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Helweg-Larsen</surname><given-names>K</given-names></name></person-group>
<article-title>The Danish Register of Causes of Death</article-title>. <source>Scand J Public Health</source>
<year>2011</year>;<volume>39</volume>:<fpage>26</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1177/1403494811399958</pub-id>
</mixed-citation></ref><ref id="R82"><label>82.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ibfelt</surname><given-names>EH</given-names></name>, <name name-style="western"><surname>S&#x000f8;rensen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>DV</given-names></name>, <etal>et al</etal></person-group>
<article-title>Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry</article-title>. <source>Clin Epidemiol</source>
<year>2017</year>;<volume>9</volume>:<fpage>627</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.2147/CLEP.S141438</pub-id>
<pub-id pub-id-type="pmid">29238225</pub-id></mixed-citation></ref><ref id="R83"><label>83.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lindhardsen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gislason</surname><given-names>GH</given-names></name>, <name name-style="western"><surname>Jacobsen</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study</article-title>. <source>Ann Rheum Dis</source>
<year>2014</year>;<volume>73</volume>:<fpage>1515</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2012-203137</pub-id>
<pub-id pub-id-type="pmid">23749610</pub-id></mixed-citation></ref><ref id="R84"><label>84.</label><mixed-citation publication-type="journal">
<article-title>European prospective investigation into cancer and nutrition E</article-title>. <source>EPIC Study</source>
<year>2014</year>
<uri xlink:href="http://epic.iarc.fr/">http://epic.iarc.fr/</uri> (<comment>accessed March 2018</comment>).</mixed-citation></ref><ref id="R85"><label>85.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Racine</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Carbonnel</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>SS</given-names></name>, <etal>et al</etal></person-group>
<article-title>Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study</article-title>. <source>Inflamm Bowel Dis</source>
<year>2016</year>;<volume>22</volume>:<fpage>345</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1097/MIB.0000000000000638</pub-id>
<pub-id pub-id-type="pmid">26717318</pub-id></mixed-citation></ref><ref id="R86"><label>86.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Togo</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Heitmann</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>S&#x000f8;rensen</surname><given-names>TI</given-names></name>, <etal>et al</etal></person-group>
<article-title>Consistency of food intake factors by different dietary assessment methods and population groups</article-title>. <source>Br J Nutr</source>
<year>2003</year>;<volume>90</volume>:<fpage>667</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1079/BJN2003943</pub-id>
<pub-id pub-id-type="pmid">13129474</pub-id></mixed-citation></ref><ref id="R87"><label>87.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tj&#x000f8;nneland</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Overvad</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Haraldsd&#x000f3;ttir</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Validation of a semiquantitative food frequency questionnaire developed in Denmark</article-title>. <source>Int J Epidemiol</source>
<year>1991</year>;<volume>20</volume>:<fpage>906</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">1800429</pub-id></mixed-citation></ref><ref id="R88"><label>88.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Osler</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Heitmann</surname><given-names>BL</given-names></name></person-group>
<article-title>The validity of a short food frequency questionnaire and its ability to measure changes in food intake: a longitudinal study</article-title>. <source>Int J Epidemiol</source>
<year>1996</year>;<volume>25</volume>:<fpage>1023</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/ije/25.5.1023</pub-id>
<pub-id pub-id-type="pmid">8921490</pub-id></mixed-citation></ref><ref id="R89"><label>89.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>K&#x000f8;ster-Rasmussen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Siersma</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Halldorsson</surname><given-names>TI</given-names></name>, <etal>et al</etal></person-group>
<article-title>Missing portion sizes in FFQ&#x02013;alternatives to use of standard portions</article-title>. <source>Public Health Nutr</source>
<year>2015</year>;<volume>18</volume>:<fpage>1914</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1017/S1368980014002389</pub-id>
<pub-id pub-id-type="pmid">25382388</pub-id></mixed-citation></ref><ref id="R90"><label>90.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tjonneland</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Haraldsd&#x000f3;ttir</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Overvad</surname><given-names>K</given-names></name>, <etal>et al</etal></person-group>
<article-title>Influence of individually estimated portion size data on the validity of a semiquantitative food frequency questionnaire</article-title>. <source>Int J Epidemiol</source>
<year>1992</year>;<volume>21</volume>:<fpage>770</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/ije/21.4.770</pub-id>
<pub-id pub-id-type="pmid">1521982</pub-id></mixed-citation></ref><ref id="R91"><label>91.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Feskanich</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rimm</surname><given-names>EB</given-names></name>, <name name-style="western"><surname>Giovannucci</surname><given-names>EL</given-names></name>, <etal>et al</etal></person-group>
<article-title>Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire</article-title>. <source>J Am Diet Assoc</source>
<year>1993</year>;<volume>93</volume>:<fpage>790</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/0002-8223(93)91754-E</pub-id>
<pub-id pub-id-type="pmid">8320406</pub-id></mixed-citation></ref><ref id="R92"><label>92.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hunter</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Sampson</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Stampfer</surname><given-names>MJ</given-names></name>, <etal>et al</etal></person-group>
<article-title>Variability in portion sizes of commonly consumed foods among a population of women in the United States</article-title>. <source>Am J Epidemiol</source>
<year>1988</year>;<volume>127</volume>:<fpage>1240</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a114916</pub-id>
<pub-id pub-id-type="pmid">3369422</pub-id></mixed-citation></ref><ref id="R93"><label>93.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Andersen</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Luben</surname><given-names>R</given-names></name>, <etal>et al</etal></person-group>
<article-title>Fibre intake and the development of inflammatory bowel disease: A European prospective multi-centre cohort study (EPIC-IBD)</article-title>. <source>J Crohns Colitis</source>
<year>2018</year>;<volume>12</volume>:<fpage>129</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjx136</pub-id>
<pub-id pub-id-type="pmid">29373726</pub-id></mixed-citation></ref><ref id="R94"><label>94.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Goldbohm</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>van &#x02019;t Veer</surname><given-names>P</given-names></name>, <name name-style="western"><surname>van den Brandt</surname><given-names>PA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five annually repeated measurements</article-title>. <source>Eur J Clin Nutr</source>
<year>1995</year>;<volume>49</volume>:<fpage>420</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">7656885</pub-id></mixed-citation></ref><ref id="R95"><label>95.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Johnsen</surname><given-names>NF</given-names></name>, <name name-style="western"><surname>Christensen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Thomsen</surname><given-names>BL</given-names></name>, <etal>et al</etal></person-group>
<article-title>Physical activity and risk of colon cancer in a cohort of Danish middle-aged men and women</article-title>. <source>Eur J Epidemiol</source>
<year>2006</year>;<volume>21</volume>:<fpage>877</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1007/s10654-006-9076-z</pub-id>
<pub-id pub-id-type="pmid">17160429</pub-id></mixed-citation></ref><ref id="R96"><label>96.</label><mixed-citation publication-type="journal">
<article-title>uk biobank</article-title>. <source>Improving the health of future generations</source>
<uri xlink:href="http://www.ukbiobank.ac.uk/">http://www.ukbiobank.ac.uk/</uri> (<comment>accessed May 2018</comment>).</mixed-citation></ref><ref id="R97"><label>97.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Andersen</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Vogel</surname><given-names>U</given-names></name></person-group>
<article-title>Dietary fibres and meat in relation to Colorectal Cancer</article-title>. <source>Norske Gastroenterologisk Forening-nytt</source>
<year>2014</year>;<volume>21</volume>:<fpage>34</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="R98"><label>98.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Devkota</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Musch</surname><given-names>MW</given-names></name>, <etal>et al</etal></person-group>
<article-title>Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice</article-title>. <source>Nature</source>
<year>2012</year>;<volume>487</volume>:<fpage>104</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">22722865</pub-id></mixed-citation></ref><ref id="R99"><label>99.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Strober</surname><given-names>W</given-names></name></person-group>
<article-title>Vitamin A rewrites the ABCs of oral tolerance</article-title>. <source>Mucosal immunology</source>
<year>2008</year>;<volume>1</volume>:<fpage>92</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">19079166</pub-id></mixed-citation></ref><ref id="R100"><label>100.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Agmon-Levin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Theodor</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Segal</surname><given-names>RM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Vitamin D in systemic and organ-specific autoimmune diseases</article-title>. <source>Clinical reviews in allergy &#x00026; immunology</source>
<year>2013</year>;<volume>45</volume>:<fpage>256</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">23238772</pub-id></mixed-citation></ref><ref id="R101"><label>101.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kaulmann</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bohn</surname><given-names>T</given-names></name></person-group>
<article-title>Carotenoids, inflammation, and oxidative stress&#x02013;implications of cellular signaling pathways and relation to chronic disease prevention</article-title>. <source>Nutr Res</source>
<year>2014</year>;<volume>34</volume>:<fpage>907</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.nutres.2014.07.010</pub-id>
<pub-id pub-id-type="pmid">25134454</pub-id></mixed-citation></ref><ref id="R102"><label>102.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ejsing-Duun</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Josephsen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Aasted</surname><given-names>B</given-names></name>, <etal>et al</etal></person-group>
<article-title>Dietary gluten reduces the number of intestinal regulatory T cells in mice</article-title>. <source>Scandinavian journal of immunology</source>
<year>2008</year>;<volume>67</volume>:<fpage>553</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">18476878</pub-id></mixed-citation></ref><ref id="R103"><label>103.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Campbell</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Koch</surname><given-names>MA</given-names></name></person-group>
<article-title>Phenotypical and functional specialization of FOXP3+ regulatory T cells</article-title>. <source>Nat Rev Immunol</source>
<year>2011</year>;<volume>11</volume>:<fpage>119</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1038/nri2916</pub-id>
<pub-id pub-id-type="pmid">21267013</pub-id></mixed-citation></ref><ref id="R104"><label>104.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pedros</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Duguet</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Saoudi</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Disrupted regulatory T cell homeostasis in inflammatory bowel diseases</article-title>. <source>World J Gastroenterol</source>
<year>2016</year>;<volume>22</volume>:<fpage>974</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v22.i3.974</pub-id>
<pub-id pub-id-type="pmid">26811641</pub-id></mixed-citation></ref><ref id="R105"><label>105.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yao</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Muir</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Gibson</surname><given-names>PR</given-names></name></person-group>
<article-title>Review article: insights into colonic protein fermentation, its modulation and potential health implications</article-title>. <source>Aliment Pharmacol Ther</source>
<year>2016</year>;<volume>43</volume>:<fpage>181</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1111/apt.13456</pub-id>
<pub-id pub-id-type="pmid">26527169</pub-id></mixed-citation></ref><ref id="R106"><label>106.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rooks</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Garrett</surname><given-names>WS</given-names></name></person-group>
<article-title>Gut microbiota, metabolites and host immunity</article-title>. <source>Nat Rev Immunol</source>
<year>2016</year>;<volume>16</volume>:<fpage>341</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2016.42</pub-id>
<pub-id pub-id-type="pmid">27231050</pub-id></mixed-citation></ref><ref id="R107"><label>107.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Desai</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Seekatz</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Koropatkin</surname><given-names>NM</given-names></name>, <etal>et al</etal></person-group>
<article-title>A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility</article-title>. <source>Cell</source>
<year>2016</year>;<volume>167</volume>:<fpage>1339</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.10.043</pub-id>
<pub-id pub-id-type="pmid">27863247</pub-id></mixed-citation></ref><ref id="R108"><label>108.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Png</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Lind&#x000e9;n</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Gilshenan</surname><given-names>KS</given-names></name>, <etal>et al</etal></person-group>
<article-title>Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria</article-title>. <source>Am J Gastroenterol</source>
<year>2010</year>;<volume>105</volume>:<fpage>2420</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/ajg.2010.281</pub-id>
<pub-id pub-id-type="pmid">20648002</pub-id></mixed-citation></ref><ref id="R109"><label>109.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Windey</surname><given-names>K</given-names></name>, <name name-style="western"><surname>De Preter</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Louat</surname><given-names>T</given-names></name>, <etal>et al</etal></person-group>
<article-title>Modulation of protein fermentation does not affect fecal water toxicity: a randomized cross-over study in healthy subjects</article-title>. <source>PLoS One</source>
<year>2012</year>;<volume>7</volume>:<elocation-id>e52387</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0052387</pub-id>
<pub-id pub-id-type="pmid">23285019</pub-id></mixed-citation></ref><ref id="R110"><label>110.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ijssennagger</surname><given-names>N</given-names></name>, <name name-style="western"><surname>van der Meer</surname><given-names>R</given-names></name>, <name name-style="western"><surname>van Mil</surname><given-names>SWC</given-names></name></person-group>
<article-title>Sulfide as a Mucus Barrier-Breaker in Inflammatory Bowel Disease?</article-title>
<source>Trends Mol Med</source>
<year>2016</year>;<volume>22</volume>:<fpage>190</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2016.01.002</pub-id>
<pub-id pub-id-type="pmid">26852376</pub-id></mixed-citation></ref><ref id="R111"><label>111.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gibson</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Macfarlane</surname><given-names>GT</given-names></name>, <name name-style="western"><surname>Cummings</surname><given-names>JH</given-names></name></person-group>
<article-title>Sulphate reducing bacteria and hydrogen metabolism in the human large intestine</article-title>. <source>Gut</source>
<year>1993</year>;<volume>34</volume>:<fpage>437</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/gut.34.4.437</pub-id>
<pub-id pub-id-type="pmid">8491386</pub-id></mixed-citation></ref><ref id="R112"><label>112.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Maloy</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Powrie</surname><given-names>F</given-names></name></person-group>
<article-title>Intestinal homeostasis and its breakdown in inflammatory bowel disease</article-title>. <source>Nature</source>
<year>2011</year>;<volume>474</volume>:<fpage>298</fpage>&#x02013;<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1038/nature10208</pub-id>
<pub-id pub-id-type="pmid">21677746</pub-id></mixed-citation></ref><ref id="R113"><label>113.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>HY</given-names></name>, <etal>et al</etal></person-group>
<article-title>Mechanisms and pathways of innate immune activation and regulation in health and cancer</article-title>. <source>Hum Vaccin Immunother</source>
<year>2014</year>;<volume>10</volume>:<fpage>3270</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.4161/21645515.2014.979640</pub-id>
<pub-id pub-id-type="pmid">25625930</pub-id></mixed-citation></ref><ref id="R114"><label>114.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jia</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Whitehead</surname><given-names>RN</given-names></name>, <name name-style="western"><surname>Griffiths</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group>
<article-title>Diversity and distribution of sulphate-reducing bacteria in human faeces from healthy subjects and patients with inflammatory bowel disease</article-title>. <source>FEMS Immunol Med Microbiol</source>
<year>2012</year>;<volume>65</volume>:<fpage>55</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-695X.2012.00935.x</pub-id>
<pub-id pub-id-type="pmid">22309113</pub-id></mixed-citation></ref><ref id="R115"><label>115.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Larsen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Larsen</surname><given-names>MD</given-names></name>, <etal>et al</etal></person-group>
<article-title>The Danish National Registry for Biological Therapy in Inflammatory Bowel Disease</article-title>. <source>Clin Epidemiol</source>
<year>2016</year>;<volume>8</volume>:<fpage>607</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.2147/CLEP.S99478</pub-id>
<pub-id pub-id-type="pmid">27822107</pub-id></mixed-citation></ref></ref-list></back></article>